• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identifying families with likely genetic protective factors against Alzheimer disease.识别可能具有预防阿尔茨海默病遗传保护因素的家族。
Am J Hum Genet. 1999 Mar;64(3):832-8. doi: 10.1086/302280.
2
Familial patterns of risk in very late-onset Alzheimer disease.晚发型阿尔茨海默病的家族风险模式。
Arch Gen Psychiatry. 2003 Feb;60(2):190-7. doi: 10.1001/archpsyc.60.2.190.
3
Variability of familial risk of Alzheimer disease across the late life span.阿尔茨海默病家族风险在晚年阶段的变异性。
Arch Gen Psychiatry. 2005 May;62(5):565-73. doi: 10.1001/archpsyc.62.5.565.
4
Role of familial factors in late-onset Alzheimer disease as a function of age.家族因素在晚发型阿尔茨海默病中作为年龄函数的作用。
Alzheimer Dis Assoc Disord. 1998 Sep;12(3):190-7. doi: 10.1097/00002093-199809000-00011.
5
Patterns of risk in first-degree relatives of patients with Alzheimer's disease.阿尔茨海默病患者一级亲属的风险模式。
Arch Gen Psychiatry. 1994 Jul;51(7):577-86. doi: 10.1001/archpsyc.1994.03950070069012.
6
Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.载脂蛋白E-ε4等位基因与阿尔茨海默病的家族风险
Genet Epidemiol. 1996;13(3):285-98. doi: 10.1002/(SICI)1098-2272(1996)13:3<285::AID-GEPI5>3.0.CO;2-5.
7
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part VI. Family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls.建立阿尔茨海默病注册机构联盟(CERAD)。第六部分。家族史评估:阿尔茨海默病先证者的一级亲属和非痴呆配偶对照的多中心研究。
Neurology. 1994 Jul;44(7):1253-9. doi: 10.1212/wnl.44.7.1253.
8
Assessment of genetic risk for Alzheimer's disease among first-degree relatives.对一级亲属中阿尔茨海默病遗传风险的评估。
Ann Neurol. 1989 May;25(5):485-93. doi: 10.1002/ana.410250511.
9
Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.载脂蛋白Eε4等位基因与阿尔茨海默病的家族聚集性。
Arch Neurol. 1998 Jun;55(6):810-6. doi: 10.1001/archneur.55.6.810.
10
A phenotype for genetic studies of successful cognitive aging.一种用于成功认知老化基因研究的表型。
Am J Med Genet B Neuropsychiatr Genet. 2008 Mar 5;147B(2):167-73. doi: 10.1002/ajmg.b.30483.

引用本文的文献

1
The 100-plus Study of cognitively healthy centenarians: rationale, design and cohort description.百岁认知健康研究:原理、设计和队列描述。
Eur J Epidemiol. 2018 Dec;33(12):1229-1249. doi: 10.1007/s10654-018-0451-3. Epub 2018 Oct 25.
2
Haemoglobin A(1c) and cognitive function in very old, cognitively intact men.高龄认知功能正常男性的糖化血红蛋白A1c与认知功能
Age Ageing. 2012 Jan;41(1):125-8. doi: 10.1093/ageing/afr124. Epub 2011 Sep 18.
3
Heritability of cognitive functions in families of successful cognitive aging probands from the Central Valley of Costa Rica.成功认知老化被试者的中美洲哥斯达黎加中央山谷家族的认知功能遗传率。
J Alzheimers Dis. 2011;27(4):897-907. doi: 10.3233/JAD-2011-110782.
4
Memory activation in healthy nonagenarians.健康的 90 多岁老人的记忆激活。
Neurobiol Aging. 2011 Mar;32(3):515-23. doi: 10.1016/j.neurobiolaging.2009.02.022. Epub 2009 Apr 1.
5
The neuropsychological performance of nondemented Puerto Rican nonagenarians.非痴呆波多黎各百岁老人的神经心理学表现。
Dement Geriatr Cogn Disord. 2009;27(4):353-60. doi: 10.1159/000209213. Epub 2009 Mar 17.
6
Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan.基于单倍型鉴定与人类寿命相关的微粒体转移蛋白标志物。
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14115-20. doi: 10.1073/pnas.1936249100. Epub 2003 Nov 13.
7
Life-long sustained mortality advantage of siblings of centenarians.百岁老人的兄弟姐妹终身具有持续的死亡率优势。
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8442-7. doi: 10.1073/pnas.122587599.

本文引用的文献

1
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.年龄、性别和种族对载脂蛋白E基因型与阿尔茨海默病之间关联的影响。一项荟萃分析。载脂蛋白E与阿尔茨海默病荟萃分析联盟。
JAMA. 1997;278(16):1349-56.
2
[Tokyo Centenarian Study. 4. Apolipoprotein E phenotype in Japanese centenarians living in the Tokyo Metropolitan area].[东京百岁老人研究。4. 居住在东京都市区的日本百岁老人的载脂蛋白E表型]
Nihon Ronen Igakkai Zasshi. 1997 Apr;34(4):267-72. doi: 10.3143/geriatrics.34.267.
3
HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease.与晚发性阿尔茨海默病主要遗传风险相关的人类白细胞抗原-DR抗原
Neuroreport. 1997 Apr 14;8(6):1467-9. doi: 10.1097/00001756-199704140-00028.
4
The validity of the family history method for identifying Alzheimer disease.家族史法用于识别阿尔茨海默病的有效性。
Arch Neurol. 1997 May;54(5):634-40. doi: 10.1001/archneur.1997.00550170104021.
5
Apolipoprotein E and Alzheimer's disease: a review of recent studies.载脂蛋白E与阿尔茨海默病:近期研究综述
Pharmacol Biochem Behav. 1997 Apr;56(4):675-85. doi: 10.1016/s0091-3057(96)00420-0.
6
In an epidemiological sample the apolipoprotein E4 allele is associated to dementia and loss of memory function only in the very old.在一个流行病学样本中,载脂蛋白E4等位基因仅在高龄人群中与痴呆和记忆功能丧失有关。
Neurosci Lett. 1997 Jan 24;222(1):29-32. doi: 10.1016/s0304-3940(97)13334-1.
7
Genes contributing to Alzheimer's disease.导致阿尔茨海默病的基因。
Mol Psychiatry. 1996 Mar;1(1):27-40.
8
A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.一项针对老年人认知健康的前瞻性研究(俄勒冈脑老化研究):家族史和载脂蛋白E基因型的影响。
Am J Hum Genet. 1997 Apr;60(4):948-56.
9
ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.载脂蛋白E-4与阿尔茨海默病发病年龄:美国国立精神卫生研究所遗传学倡议
Neurology. 1997 Jan;48(1):139-47. doi: 10.1212/wnl.48.1.139.
10
Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study.在一项为期3年的基于人群的随访研究中,不同载脂蛋白E表型的人类受试者的记忆功能。
Neurosci Lett. 1996 Feb 9;204(3):177-80. doi: 10.1016/0304-3940(96)12348-x.

识别可能具有预防阿尔茨海默病遗传保护因素的家族。

Identifying families with likely genetic protective factors against Alzheimer disease.

作者信息

Silverman J M, Smith C J, Marin D B, Birstein S, Mare M, Mohs R C, Davis K L

机构信息

Department of Psychiatry, Mt. Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.

出版信息

Am J Hum Genet. 1999 Mar;64(3):832-8. doi: 10.1086/302280.

DOI:10.1086/302280
PMID:10053018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1377801/
Abstract

Elderly individuals who lived beyond the age of 90 years without dementia were hypothesized to have increased concentrations of genetic protective factors against Alzheimer disease (AD), conferring a reduced liability for this disease relative to less-aged nondemented elderly. However, testing this hypothesis is complicated by having to distinguish such a group from those who may lack genetic risk factors for AD, have had protective environmental exposures, or have escaped dementia for other reasons. Probands carrying genetic protective factors, however, should have relatives with lower illness rates not only for earlier-onset disease, when genetic risk factors are a strong contributing factor to the incidence of AD, but also for later-onset disease, when the role of these factors appears to be markedly diminished. AD dementia was assessed through family informants in 6,660 first-degree relatives of 1,049 nondemented probands aged 60-102 years. The probands were grouped by age (60-74, 75-89, and 90-102 years), and the cumulative survival from AD and 10-year-age-interval hazard rates of AD were calculated in their first-degree relatives. Cumulative survival from AD was significantly greater in the relatives of the oldest proband group (aged 90-102 years) than it was in the two younger groups. In addition, the reduction in the rate of illness for this group was relatively constant across the entire late life span. The results suggest that genetic factors conferring a lifelong reduced liability of AD may be more highly concentrated among nondemented probands aged >/=90 years and their relatives. Efforts to identify protective allele-bearing genes that are associated with very late-onset AD should target the families of nonagenarians and centenarians.

摘要

据推测,活到90岁以上且无痴呆症的老年人具有更多针对阿尔茨海默病(AD)的遗传保护因子,与年龄较小的无痴呆症老年人相比,患这种疾病的可能性降低。然而,要验证这一假设很复杂,因为必须将这一群体与那些可能缺乏AD遗传风险因素、有保护性环境暴露或因其他原因未患痴呆症的人区分开来。然而,携带遗传保护因子的先证者的亲属不仅在早发性疾病(此时遗传风险因素是AD发病的重要因素)中的患病率较低,而且在晚发性疾病(此时这些因素的作用似乎明显减弱)中的患病率也较低。通过家庭 informant 对1049名60 - 102岁无痴呆症先证者的6660名一级亲属进行了AD痴呆评估。先证者按年龄分组(60 - 74岁、75 - 89岁和90 - 102岁),并计算其一级亲属中AD的累积生存率和10年年龄间隔AD风险率。年龄最大的先证者组(90 - 102岁)的亲属中AD的累积生存率显著高于两个较年轻的组。此外,该组疾病发生率的降低在整个晚年相对恒定。结果表明,赋予终身降低AD患病可能性的遗传因素可能在90岁及以上的无痴呆症先证者及其亲属中更为集中。识别与极晚发性AD相关的携带保护性等位基因的基因的工作应针对九旬老人和百岁老人的家庭。